Company says fiscal 2027 will focus on technology and product development and customer engagement expansion
Aeluma is negotiating NRE agreements with prospective customers in the AI datacom industry
Company says CHIPS R&D funding, if finalized, could accelerate commercialization timeline
Overview
US semiconductor firm's Q4 revenue fell yr/yr, driven by R&D contracts
Net loss and adjusted EBITDA loss widened due to investments in hiring and manufacturing
Company signed CHIPS LOI for up to $30 mln and expanded Sumitomo partnership
Result Drivers
Investments in team and manufacturing - Co said increased net loss and adjusted EBITDA loss were due to investments in hiring and manufacturing readiness
New contracts and partnerships - Co executed six new contracts totaling $5.3 mln and expanded relationships with Tower Semiconductor and Sumitomo Chemical Advanced Technologies
Increased manufacturing capacity - Co procured additional MOCVD tools to increase wafer production for non-InP platforms
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Aeluma Inc is $30.00, about 128.5% above its September 15 closing price of $13.13
ALMU•
